Debamestrocel (NurOwn) is under development for the treatment of neurodegenerative diseases such as Alzheimer's disease, amyotrophic lateral sclerosis (ALS), progressive multiple sclerosis (primary ...

The study, published in Neuron, describes microglia—the brain’s primary immune cells—as pivotal players in both protective and harmful responses related to AD. Microglia, often described as the ...